This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
O Agid , T Arenovich , G Sajeev , RB Zipursky , (2011). An algorithm-based approach to first-episode schizophrenia: response rates over 3 prospective antipsychotic trials with a retrospective data analysis. Journal of Clinical Psychiatry 72, 1439–1444.
C Arango , I Bombin , T Gonzalez-Salvador , I Garcia-Cabeza , (2006). Randomised clinical trial comparing oral vs. depot formulations of zuclopenthixol in patients with schizophrenia and previous violence. European Psychiatry 21, 34–40.
H Ascher-Svanum , D Faries , B Zhu , FR Ernst , (2006). Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. Journal of Clinical Psychiatry 67, 453–460.
CA Asenjo , K Komossa , S Leucht , H Hunger , (2010). Clozapine vs. other atypical antipsychotics for schizophrenia. Cochrane Database of Systematic Reviews. Issue No. 11. Article No.: CD006633.
BB Averbeck , S Evans , V Chouhan , E Bristow , (2011). Probabilistic learning and inference in schizophrenia. Schizophrenia Research 127, 115–122.
EA Barrett (2011). Neurocognitive functioning and suicidality in schizophrenia spectrum disorders. Comprehensive Psychiatry 52, 156–163.
A Becker , G Grecksch (2003). Haloperidol and clozapine affect social behaviour in rats postnatally lesioned in the ventral hippocampus. Pharmacology Biochemistry and Behavior 76, 1–8.
L Beherec , S Lambrey , G Quilici , A Rosier , (2011). Retrospective review of clozapine in the treatment of patients with autism spectrum disorder and severe disruptive behaviors. Journal of Clinical Psychopharmacology 31, 341–344.
F Benedetti , L Sforzini , C Colombo , C Maffei , (1998). Low-dose clozapine in acute and continuation treatment of severe borderline personality disorder. Journal of Clinical Psychiatry 59, 103–107.
RM Bilder , RS Goldman , J Volavka , P Czobor , (2002). Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. American Journal of Psychiatry 159, 1018–1028.
I Bitter , P Czobor , M Dossenbach , J Volavka (2005). Effectiveness of clozapine, olanzapine, quetiapine, risperidone, and haloperidol monotherapy in reducing hostile behaviour in outpatients treated for schizophrenia: a prospective naturalistic study (IC SOHO). European Psychiatry 20, 403–408.
A Boachie , MGA McGinnity (1997). Use of clozapine in a mental handicap hospital – report of the first 17 patients. Irish Journal of Psychological Medicine 14, 16–19.
PF Buckley , N Shendarkar (2005). Treatment-refractory schizophrenia. Current Opinion in Psychiatry 18, 165–173.
M Chakos , J Lieberman , E Hoffman , D Bradford , (2001). Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. American Journal of Psychiatry 158, 518–526.
DT Chau , D Gulick , H Xie , R Dawson , (2010). Clozapine chronically suppresses alcohol drinking in Syrian golden hamsters. Neuropharmacology 58, 351–356.
KNR Chengappa , T Ebeling , JS Kang , J Levine , (1999). Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorder. Journal of Clinical Psychiatry 60, 477–484.
KNR Chengappa , J Vasile , J Levine , R Ulrich , (2002). Clozapine: its impact on aggressive behavior among patients in a state psychiatric hospital. Schizophrenia Research 53, 1–6.
L Citrome , J Volavka (2000). Management of violence in schizophrenia. Psychiatric Annals 30, 41–52.
L Citrome , J Volavka , P Czobor , B Sheitman , (2001). Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia. Psychiatric Services 52, 1510–1514.
B Dalal , E Larkin , M Leese , PJ Taylor (1999). Clozapine treatment of long-standing schizophrenia and serious violence: a two-year follow-up study of the first 50 patients treated with clozapine in Rampton high security hospital. Criminal Behaviour and Mental Health 9, 168–178.
P De Domenico , AE Di Rosa , AA D'Agostino , G Martino , (1999). The effect of clozapine on aggressive behaviour in patients with chronic schizophrenia. International Journal of Psychiatry in Clinical Practice 3, 49–54.
M De Hert , CU Correll , D Cohen (2010). Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study. Schizophrenia Research 117, 68–74.
J de Leon , FJ Diaz , RC Josiassen , TB Cooper , (2005). Does clozapine decrease smoking? Progress in Neuro-Psychopharmacology and Biological Psychiatry 29, 757–762.
KS Douglas , LS Guy , SD Hart (2009). Psychosis as a risk factor for violence to others: a meta-analysis. Psychological Bulletin 135, 679–706.
KFW Dyer , MJ Dorahy , G Hamilton , M Corry , (2009). Anger, aggression, and self-harm in PTSD and complex PTSD. Journal of Clinical Psychology 65, 1099–1114.
A Essali , N Al-Haj Hassan , J Rathbone (2009). Clozapine vs. typical neuroleptic medication for schizophrenia. Cochrane Database of Systematic Reviews. Issue No. 1. Art. No. CD000059.
S Fazel , G Gulati , L Linsell , JR Geddes , (2009 a). Schizophrenia and violence: systematic review and meta-analysis. PLoS Medicine 6, 1–15.
S Fazel , N Langstrom , A Hjern , M Grann , (2009 b). Schizophrenia, substance abuse, and violent crime. Journal of the American Medical Association 301, 2016–2023.
FR Frankenburg , MC Zanarini (1993). Clozapine treatment of borderline patients: a preliminary study. Comprehensive Psychiatry 34, 402–405.
WG Frankle , D Shera , H Berger-Hershkowitz , AE Evins , (2001). Clozapine-associated reduction arrest rates, of psychotic patients with criminal histories. American Journal of Psychiatry 158, 270–274.
A Gallitano-Mendel , DF Wozniak , EA Pehek , J Milbrandt (2008). Mice lacking the immediate early gene Egr3 respond to the anti-aggressive effects of clozapine yet are relatively resistant to its sedating effects. Neuropsychopharmacology 33, 1266–1275.
L Garmendia , JR Sanchez , A Azpiroz , PF Brain , (1992). Clozapine: strong antiaggressive effects with minimal motor impairment. Physiology and Behavior 51, 51–54.
RR Girgis , MR Phillips , L Xiaodong , L Kejing , (2011). Clozapine v. chlorpromazine in treatment-naive, first-episode schizophrenia: 9-year outcomes of a randomised clinical trial. British Journal of Psychiatry 199, 281–288.
A Green , ES Burgess , R Dawson , SV Zimmet , (2003). Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone . Schizophrenia Research 60, 81–85.
A Green , DL Noordsy , M Brunette , CD O'Keefe (2008). Substance abuse and schizophrenia: pharmacotherapeutic intervention. Journal of Substance Abuse Treatment 34, 61–71.
C Hagger , P Buckley , JT Kenny , L Freidman , (1993). Improvement in cognitive function and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine. Biological Psychiatry 34, 702–712.
R Hammock , WR Levine , SR Schroeder (2001). Brief report: effects of clozapine on self-injurious behavior of two risperidone nonresponders with mental retardation. Journal of Autism and Developmental Disorders 31, 109–113.
J Hennen , RJ Baldessarini (2005). Suicidal risk during treatment with clozapine: a meta-analysis. Schizophrenia Research 73, 139–145.
JN Herrera , JJ Sramek , JF Costa , S Roy , (1988). High potency neuroleptics and violence in schizophrenics. Journal of Nervous and Mental Disease 176, 558–561.
M Hillbrand (1995). Aggression against self and aggression against others in violent psychiatric patients. Journal of Consulting and Clinical Psychology 63, 668–671.
N Huband , M Ferriter , R Nathan , H Jones (2010). Antiepileptics for aggression and associated impulsivity. Cochrane database of Systematic Reviews. Issue No. 2. Art No. CD003499.
I Iancu , E Bodner , S Roitman , SA Piccone , (2010). Impulsivity, aggression and suicide risk among male schizophrenia patients. Psychopathology 43, 223–229.
MA Ilgen , ML Burnette , KR Conner , E Czyz , (2010). The association between violence and lifetime suicidal thoughts and behaviours in individuals treated for substance use disorders. Addictive Behaviours 35, 111–115.
J Kane , G Honigfeld , J Singer , HY Meltzer , (1988). Clozapine for the treatment-resistant schizophrenic. Archives of General Psychiatry 45, 789–796.
J Kane , N Schooler , SR Marder , W Wirshing , (1996). Efficacy of clozapine vs. haloperidol in a long-term clinical trial. Schizophrenia Research 18, 127.
SR Kay , F Wolkenfelf , LM Murrill (1988). Profiles of aggression among psychiatric patients: I. nature and prevalence. Journal of Nervous and Mental Disease 176, 539–546.
E Kim , S Gupta , S Bolge , CC Chen , (2010). Adherence and outcomes associated with copayment burden in schizophrenia: a cross-sectional survey. Journal of Medical Economics 13, 185–192.
H Koike , D Ibi , H Mizoguchi , T Nagai , (2009). Behavioral abnormality and pharmacologic response in social isolation-reared mice. Behavioural Brain Research 202, 114–121.
RA Kowatch , T Suppes , SK Gilfillan , RM Fuentes , (1995). Clozapine treatment of children and adolescents with bipolar disorder and schizophrenia: a clinical case series. Journal of Child and Adolescent Psychopharmacology 5, 241–253.
MI Krakowski , P Czobor , L Citrome , N Bark , (2006). Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder. Archives of General Psychiatry 63, 622–629.
MI Krakowski , P Czobor , KA Nolan (2008). Atypical antipsychotics, neurocognitive deficits, and aggression in schizophrenic patients. Journal of Clinical Psychopharmacology 28, 485–493.
H Kranzler , D Roofeh , G Gerbino-Rosen , C Dombrowski , (2005). Clozapine: its impact on aggressive behavior among children and adolescents with schizophrenia. Journal of the American Academy of Child and Adolescent Psychiatry 44, 55–63.
JE Kraus , B Sheitman (2005). Clozapine reduces violent behavior in heterogeneous diagnostic groups. Journal of Neuropsychiatry and Clinical Neurosciences 17, 36–44.
V Kumari , I Barkataki , S Goswami , S Flora , (2009). Dysfunctional, but not functional, impulsivity is associated with a history of seriously violent behaviour and reduced orbitofrontal and hippocampal volumes in schizophrenia. Psychiatry Research Neuroimaging 173, 39–44.
S Lambrey , B Falissard , M Martin-Barrero , C Bonnefoy , et al. (2010). Effectiveness of clozapine for the treatment of aggression in an adolescent with autistic disorder. Journal of Child and Adolescent Psychopharamacology 20, 79–80.
MA Lee , K Jayathilake , H Meltzer (1999). A comparison of the effect of clozapine with typical neuroleptics on cognitive function in neuroleptic-responsive schizophrenia. Schizophrenia Research 37, 1–11.
S Leucht , C Corves , D Arbter , RR Engel , (2009 a). Second-generation vs. first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 373, 31–41.
S Leucht , D Arbter , RR Engel , W Kissling , JM Davis (2009 b). How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials. Molecular Psychiatry 14, 429–447.
TM Lincoln , J Lange , J Burau , C Exner , (2010). The effect of state anxiety on paranoid ideation and jumping to conclusions. An experimental investigation. Schizophrenia Bulletin 36, 1140–1148.
BG Link , A Stueve , J Phelan (1998). Psychotic symptoms and violent behaviors: probing the components of ‘threat/control-override’ symptoms. Social Psychiatry and Psychiatric Epidemiology 33, S55–S60.
P Manu , D Sarpal , O Muir , JM Kane , (2011). When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature. Schizophrenia Research 134, 180–186.
J McEvoy , O Freudenreich , WH Wilson (1999). Smoking and therapeutic response to clozapine in patients with schizophrenia. Biological Psychiatry 46, 125–129.
BA McMillen , EA DaVanzo , AH Song , SM Scott , (1989). Effects of classical and atypical antipsychotic drugs on isolation-induced aggression in male mice. European Journal of Pharmacology 160, 149–153.
H Meltzer , SR McGurk (1999). The effects of clozapine, risperidone and olanzapine on cognitive function in schizophrenia. Schizophrenia Bulletin 25, 233–255.
HY Meltzer , L Alphs , AI Green , C Altamura , (2003). Clozapine treatment for suicidality in schizophrenia. Archives of General Psychiatry 60, 82–91.
ML Michals , ML Crimson , S Roberts , A Childs (1993). Clozapine response and adverse effects in nine brain injured patients. Journal of Clinical Psychopharmacology 13, 198–203.
I Modai , S Hirschmann , A Rava , R Kurs , (2000). Sudden death in patients receiving clozapine treatment: a preliminary investigation. Journal of Clinical Psychopharmacology 20, 325–327.
J Modestin , D Dal Pian , P Agarwalla (2005). Clozapine diminishes suicidal behavior: a retrospective evaluation of clinical records. Journal of Clinical Psychiatry 66, 534–538.
J Munro , D O'Sullivan , C Andrews , A Arana , (1999). Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance. British Journal of Psychiatry 175, 576–580.
K Nolan , P Czobor , BB Roy , MM Platt , (2003). Characteristics of assaultive behavior among psychiatric inpatients. Psychiatric Services 54, 1012–1016.
KA Nolan , D D'Angelo , MJ Hoptman (2011). Self-report and laboratory measures of impulsivity in patients with schizophrenia or schizoaffective disorder and healthy controls. Psychiatry Research 187, 301–303.
GF Parker (2002). Clozapine and borderline personality disorder. Psychiatric Services 53, 348–349.
J Phelan , BG Link (1998). The growing belief that people with mental illness are violent: the role of the dangerousness criterion for civil commitment. Social Psychiatry and Psychiatric Epidemiology 33, 7–12.
NK Popova (2008). From gene to aggressive behavior: the role of brain serotonin. Neuroscience and Behavioural Psychology 38, 471–475.
NK Popova , VS Naumenko , RV Kozhemyakina , IZ Plyusnina (2010). Functional characteristics of serotonin 5-HT2A and 5-HT2C receptors in the brain and the expression of the 5-HT2A and 5-HT2C receptor genes in aggressive and non-aggressive rats. Neuroscience and Behavioural Psychology 40, 357–361.
SG Potkin , L Alphs , C Hsu , KRT Krishnan , (2003). Predicting suicidal risk in schizophrenic and schizoaffective patients in a prospective two-year trial. Biological Psychiatry 54, 444–452.
J Rabinowitz , M Avnon , V Rosenberg (1996). Effect of clozapine on physical and verbal aggression. Schizophrenia Research 22, 249–255.
DB Ravanic , SM Djukic Dejanovic , V Janjic , SD Jovic , (2009). Effectiveness of clozapine, haloperidol and chlorpromazine in schizophrenia during a five-year period. Arquivos de Neuro-Psiquiatria 67, 195–202.
WH Reid , M Mason , T Hogan (1998). Suicide prevention effects associated with clozapine therapy in schizophrenia and schizoaffective disorder. Psychiatric Services 49, 1029–1033.
R Rimon , K Kuoppasalmi , H Naukkarinen , S Lang , (1994). Clozapine decreases the level of anxiety and aggressive behaviour in patients with therapy-refractory schizophrenia. Nordic Journal of Psychiatry 48, 315–320.
R Rosenheck , S Chang , Y Choe , J Cramer , (2000). Medication continuation and compliance: a comparison of patients treated with clozapine and haloperidol. Journal of Clinical Psychiatry 61, 382–386.
MJ Sernyak , R Desai , M Stolar , R Rosenheck (2001). Impact of clozapine on completed suicide. American Journal of Psychiatry 158, 931–937.
ZA Sharif , A Raza , SS Ratakonda (2000). Comparative efficacy of risperidone and clozapine in the treatment of patients with refractory schizophrenia or schizoaffective disorder: a retrospective analysis. Journal of Clinical Psychiatry 61, 498–504.
A Shrivastava , N Shah , M Johnson , L Stitt , (2010). Predictors of long-term outcome of first-episode schizophrenia: a ten-year follow-up study. Indian Journal of Psychiatry 52, 320–326.
H Smith , T White (2004). The effect of clozapine on the social behaviour schedule in patients attending a forensic psychiatry day hospital. Medicine, Science and the Law 44, 213–216.
J Smith , S Hucker (1994). Schizophrenia and substance abuse. British Journal of Psychiatry 165, 13–21.
B Spivak , R Mester , N Wittenberg , Z Maman , (1997). Reduction of aggressiveness and impulsiveness during clozapine treatment in chronic neuroleptic-resistant schizophrenic patients. Clinical Neuropharmacology 20, 442–446.
B Spivak , E Shabash , B Sheitman , A Weizman , (2003). The effects of clozapine vs. haloperidol on measures of impulsive aggression and suicidality in chronic schizophrenia patients: an open, nonrandomized, 6-month study. Journal of Clinical Psychiatry 64, 755–760.
T Steinert , C Wiebe , RT Gebhardt (1999). Aggressive behaviours against self and others among first-admission patients with schizophrenia. Psychiatric Services 50, 85–90.
RD Strous , M Kupchik , S Roitman , S Schwartz , (2006). Comparison between risperidone, olanzapine, and clozapine in the management of chronic schizophrenia: a naturalistic prospective 12-week observational study. Human Psychopharmacology 21, 235–243.
JW Swanson , RA Dom Van , MS Swartz , A Smith , (2008 a). Alternative pathways to violence in persons with schizophrenia: the role of childhood antisocial behaviour problems. Law and Human Behaviour 32, 228–240.
JW Swanson , M Swartz , RA Van Dorn , EB Elbogen , (2006). A National Study of Violent Behaviour in Persons with Schizophrenia. Archives of General Psychiatry 63, 490–499.
JW Swanson , MS Swartz , EB Elbogen (2004). Effectiveness of atypical antipsychotic medications in reducing violent behavior among persons with schizophrenia in community-based treatment. Schizophrenia Bulletin 30, 3–20.
JW Swanson , MS Swartz , RA Van Dorn , J Volavka , (2008 b). Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia. British Journal of Psychiatry 193, 37–43.
M Swinton (2001). Clozapine in severe borderline personality disorder. Journal of Forensic Psychiatry 12, 580–591.
M Swinton , A Haddock (2000). Clozapine in Special Hospital: a retrospective case-control study. Journal of Forensic Psychiatry 11, 587–596.
T Tiihonen , J Lonnqvist , K Wahlbeck , T Klaukka , (2009). 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet 374, 620–627.
A Topiwala , S Fazel (2011). The pharmacological management of violence in schizophrenia: a structured review. Expert Review of Neurotherapeutics 11, 53–63.
RA Van Dorn , R Andel , TL Boaz , SL Desmarais , (2011). Risk of arrest in persons with schizophrenia and bipolar disorder in a Florida Medicaid program: the role of atypical antipsychotics, conventional neuroleptics, and routine outpatient behavioural health services. Journal of Clinical Psychiatry 72, 502–508.
J Volavka , L Citrome (2008). Heterogeneity of violence in schizophrenia and implications for long-term treatment. International Journal of Clinical Practice 62, 1237–1245.
J Volavka , P Czobor , K Nolan , B Sheitman , (2004). Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol. Journal of Clinical Psychopharmacology 24, 225–228.
J Volavka , JM Zito , J Vitrai , P Czobor (1993). Clozapine effects on hostility and aggression in schizophrenia. Journal of Clinical Psychopharmacology 13, 287–289.
AM Walker , L Lee Lanza , F Arellano , K Rothman (1997). Mortality in current and former users of clozapine. Epidemiology 8, 671–677.
E Walsh , A Buchanan , T Fahy (2002). Violence and Schizophrenia: examining the evidence. British Journal of Psychiatry 180, 490–495.
M Wheatley , J Plant , H Reader , G Brown , (2004). Clozapine treatment of adolescents with posttraumatic stress disorder and psychotic symptoms. Journal of Clinical Psychopharmacology 24, 167–173.
SV Zimmet , RD Strous , ES Burgess , S Kohnstamm , (2000). Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey. Journal of Clinical Psychopharmacology 20, 94–98.